Skip to main content
NCBI home page
Gut logoLink to Gut
. 1986 May;27(5):559–566. doi: 10.1136/gut.27.5.559

Gall stone disease without gall stones--bile acid and bile lipid metabolism after complete gall stone dissolution.

D C Ruppin, G M Murphy, R H Dowling
PMCID: PMC1433487  PMID: 3699565

Abstract

Although bile acid and bile lipid metabolism have been studied in established cholelithiasis, little is known about them in patients destined to develop gall stones, but in whom the stones have not yet appeared (prestone gall stone disease). After confirmed complete gall stone dissolution and withdrawal of treatment, gall stones recur frequently. Before the stones reappear, these patients have 'poststone gall stone disease'. In 13 such patients we confirmed complete gall stone dissolution with two normal cholecystograms and in 11 of the 13 by normal ultrasonography, measured bile acid and bile lipid composition in fasting duodenal bile, bile acid synthesis from marker corrected three day faecal bile acid excretion, bile acid pool size using an abbreviated isotope dilution technique, 'steady-state' bile lipid secretion using a duodenal amino acid perfusion system and then calculated the enterohepatic cycling frequency of the bile acid pool and the relationship between pool size and body weight. The results confirm that after withdrawal of treatment the biliary cholesterol saturation index reverts to levels (1.6 +/- SEM 0.4) comparable with those before dissolution therapy first began (1.6 +/- 0.2; NS). The mean bile acid pool size in the 13 patients of 4.4 +/- 0.5 mmol was comparable with that in untreated gall stone patients. Pool size was significantly smaller in the nine non-obese patients (3.5 +/- 0.3), than in the four obese (6.0 +/- 0.8; p less than 0.05). It also correlated significantly with body weight (r = 0.72) and with %IBW (r = 0.79). The coefficients of variation for biliary bile acid, phospholipid and cholesterol secretion were high, but the mean hourly secretion rates were of the same order as those seen in untreated gall stone patients studied with the amino acid duodenal perfusion stimulus. These results provide a baseline for assessing the response to postdissolution treatment and may indicate metabolic events leading to gall stone formation.

Full text

PDF
559

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler R. D., Bennion L. J., Duane W. C., Grundy S. M. Effects of low dose chenodeoxycholic acid feeding on biliary lipid metabolism. Gastroenterology. 1975 Feb;68(2):326–334. [PubMed] [Google Scholar]
  2. Admirand W. H., Small D. M. The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest. 1968 May;47(5):1043–1052. doi: 10.1172/JCI105794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bell G. D., Whitney B., Dowling R. H. Gallstone dissolution in man using chenodeoxycholic acid. Lancet. 1972 Dec 9;2(7789):1213–1216. doi: 10.1016/s0140-6736(72)92266-0. [DOI] [PubMed] [Google Scholar]
  4. Bennion L. J., Drobny E., Knowler W. C., Ginsberg R. L., Garnick M. B., Adler R. D., Duane W. C. Sex differences in the size of bile acid pools. Metabolism. 1978 Aug;27(8):961–969. doi: 10.1016/0026-0495(78)90140-3. [DOI] [PubMed] [Google Scholar]
  5. Bouchier I. A., Cooperband S. R., el-Kodsi B. M. Mucous substances and viscosity of normal and pathological human bile. Gastroenterology. 1965 Oct;49(4):343–353. [PubMed] [Google Scholar]
  6. Danzinger R. G., Hofmann A. F., Schoenfield L. J., Thistle J. L. Dissolution of cholesterol gallstones by chenodeoxycholic acid. N Engl J Med. 1972 Jan 6;286(1):1–8. doi: 10.1056/NEJM197201062860101. [DOI] [PubMed] [Google Scholar]
  7. Einarsson K. A., Gundy S. M., Hardison W. G. Enterohepatic circulation rates of cholic acid and chenodeoxycholic acid in man. Gut. 1979 Dec;20(12):1078–1082. doi: 10.1136/gut.20.12.1078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Einarsson K., Hellström K., Kallner M. Gallbladder disease in hyperlipoproteinaemia. Lancet. 1975 Mar 1;1(7905):484–487. doi: 10.1016/s0140-6736(75)92831-7. [DOI] [PubMed] [Google Scholar]
  9. Everson G. T., Lawson M. J., McKinley C., Showalter R., Kern F., Jr Gallbladder and small intestinal regulation of biliary lipid secretion during intraduodenal infusion of standard stimuli. J Clin Invest. 1983 Mar;71(3):596–603. doi: 10.1172/JCI110805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Forgacs I. C., Maisey M. N., Murphy G. M., Dowling R. H. Influence of gallstones and ursodeoxycholic acid therapy on gallbladder emptying. Gastroenterology. 1984 Aug;87(2):299–307. [PubMed] [Google Scholar]
  11. Grundy S. M., Duane W. C., Adler R. D., Aron J. M., Metzger A. L. Biliary lipid outputs in young women with cholesterol gallstones. Metabolism. 1974 Jan;23(1):67–73. doi: 10.1016/0026-0495(74)90105-x. [DOI] [PubMed] [Google Scholar]
  12. Grundy S. M. Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia. J Clin Invest. 1975 Feb;55(2):269–282. doi: 10.1172/JCI107930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Grundy S. M., Metzger A. L. A physiological method for estimation of hepatic secretion of biliary lipids in man. Gastroenterology. 1972 Jun;62(6):1200–1217. [PubMed] [Google Scholar]
  14. Grundy S. M., Metzger A. L., Adler R. D. Mechanisms of lithogenic bile formation in American Indian women with cholesterol gallstones. J Clin Invest. 1972 Dec;51(12):3026–3043. doi: 10.1172/JCI107130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hegardt F. G., Dam H. The solubility of cholesterol in aqueous solutions of bile salts and lecithin. Z Ernahrungswiss. 1971 Apr;10(3):223–233. doi: 10.1007/BF02020933. [DOI] [PubMed] [Google Scholar]
  16. Holan K. R., Holzbach R. T., Hermann R. E., Cooperman A. M., Claffey W. J. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology. 1979 Oct;77(4 Pt 1):611–617. [PubMed] [Google Scholar]
  17. Holzbach R. T., Marsh M., Olszewski M., Holan K. Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man. J Clin Invest. 1973 Jun;52(6):1467–1479. doi: 10.1172/JCI107321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Iser J. H., Murphy G. M., Dowling R. H. Speed of change in biliary lipids and bile acids with chenodeoxycholic acid--is intermittent therapy feasible? Gut. 1977 Jan;18(1):7–15. doi: 10.1136/gut.18.1.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mabee T. M., Meyer P., DenBesten L., Mason E. E. The mechanism of increased gallstone formation in obese human subjects. Surgery. 1976 Apr;79(4):460–468. [PubMed] [Google Scholar]
  20. Makino I., Shinozaki K., Yoshino K., Nakagawa S. [Dissolution of cholesterol gallstones by long-term administration of ursodeoxycholic acid]. Nihon Shokakibyo Gakkai Zasshi. 1975 Jun;72(6):690–702. [PubMed] [Google Scholar]
  21. Maton P. N., Murphy G. M., Dowling R. H. Ursodeoxycholic acid treatment of gallstones. Dose-response study and possible mechanism of action. Lancet. 1977 Dec 24;2(8052-8053):1297–1301. doi: 10.1016/s0140-6736(77)90358-0. [DOI] [PubMed] [Google Scholar]
  22. Metzger A. L., Adler R., Heymsfield S., Grundy S. M. Diurnal variation in biliary lipid composition. Possible role in cholesterol gallstone formation. N Engl J Med. 1973 Feb 15;288(7):333–336. doi: 10.1056/NEJM197302152880702. [DOI] [PubMed] [Google Scholar]
  23. Mok H. Y., Von Bergmann K., Grundy S. M. Kinetics of the enterohepatic circulation during fasting: biliary lipid secretion and gallbladder storage. Gastroenterology. 1980 May;78(5 Pt 1):1023–1033. [PubMed] [Google Scholar]
  24. Mok H. Y., Von Bergmann K., Grundy S. M. Regulation of pool size of bile acids in man. Gastroenterology. 1977 Oct;73(4 Pt 1):684–690. [PubMed] [Google Scholar]
  25. Nakagawa S., Makino I., Ishizaki T., Dohi I. Dissolution of cholesterol gallstones by ursodeoxycholic acid. Lancet. 1977 Aug 20;2(8034):367–369. doi: 10.1016/s0140-6736(77)90301-4. [DOI] [PubMed] [Google Scholar]
  26. Northfield T. C., Hofmann A. F. Biliary lipid output during three meals and an overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects. Gut. 1975 Jan;16(1):1–11. doi: 10.1136/gut.16.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Northfield T. C., Hofmann A. F. Biliary lipid secretion in gallstone patients. Lancet. 1973 Apr 7;1(7806):747–748. doi: 10.1016/s0140-6736(73)92130-2. [DOI] [PubMed] [Google Scholar]
  28. Northfield T. C., LaRusso N. F., Hofmann A. F., Thistle J. L. Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects. Gut. 1975 Jan;16(1):12–17. doi: 10.1136/gut.16.1.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Pertsemlidis D., Panveliwalla D., Ahrens E. H., Jr Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man. Gastroenterology. 1974 Apr;66(4):565–573. [PubMed] [Google Scholar]
  30. Podesta M. R., Murphy G. M., Dowling R. H. Measurement of faecal bile acid sulphates. J Chromatogr. 1980 Jun 13;182(3-4):293–300. doi: 10.1016/s0378-4347(00)81477-2. [DOI] [PubMed] [Google Scholar]
  31. Pomare E. W., Heaton K. W. Bile salt metabolism in patients with gallstones in functioning gallbladders. Gut. 1973 Nov;14(11):885–890. doi: 10.1136/gut.14.11.885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Reuben A., Maton P. N., Murphy G. M., Dowling R. H. Bile lipid secretion in obese and non-obese individuals with and without gallstones. Clin Sci (Lond) 1985 Jul;69(1):71–79. doi: 10.1042/cs0690071. [DOI] [PubMed] [Google Scholar]
  33. Ruppin D. C., Dowling R. H. Is recurrence inevitable after gallstone dissolution by bile-acid treatment? Lancet. 1982 Jan 23;1(8265):181–185. doi: 10.1016/s0140-6736(82)90757-7. [DOI] [PubMed] [Google Scholar]
  34. Rutgeerts P., Ghoos Y., Vantrappen G. The enterohepatic circulation of bile acids during continuous liquid formula perfusion of the duodenum. J Lipid Res. 1983 May;24(5):614–619. [PubMed] [Google Scholar]
  35. SELIGSON D., MARINO J., DODSON E. Determination of sulfobromophthalein in serum. Clin Chem. 1957 Oct;3(5):638–645. [PubMed] [Google Scholar]
  36. Shaffer E. A., Small D. M. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity. J Clin Invest. 1977 May;59(5):828–840. doi: 10.1172/JCI108705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Small D. M. Cholesterol nucleation and growth in gallstone formation. N Engl J Med. 1980 Jun 5;302(23):1305–1307. doi: 10.1056/NEJM198006053022309. [DOI] [PubMed] [Google Scholar]
  38. Small D. M. Prestone gallstone disease--is therapy safe? N Engl J Med. 1971 Jan 28;284(4):214–215. doi: 10.1056/NEJM197101282840412. [DOI] [PubMed] [Google Scholar]
  39. Sutor D. J., Percival J. M. Presence or absence of inhibitors of crystal growth in bile. 1. Effect of bile on the formation of calcium phosphate, a constituent of gallstones. Gut. 1976 Jul;17(7):506–510. doi: 10.1136/gut.17.7.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Thistle J. L., Schoenfield L. J. Induced alterations in composition of bile of persons having cholelithiasis. Gastroenterology. 1971 Oct;61(4):488–496. [PubMed] [Google Scholar]
  41. Thomas P. J., Hofmann A. F. Letter: A simple calculation of the lithogenic index of bile: expressing biliary lipid composition on rectangular coordinates. Gastroenterology. 1973 Oct;65(4):698–700. [PubMed] [Google Scholar]
  42. Toulet J., Rousselet J., Viteau J. M., Duchon Y., Pagniez R., Samain B., Vienne J. L. Récidives et prévention des récidives après dissolution de la lithiase vésiculaire par l'acide chénodésoxycholique chez 22 patients. Gastroenterol Clin Biol. 1983 Jun-Jul;7(6-7):605–609. [PubMed] [Google Scholar]
  43. Vlahcevic Z. R., Bell C. C., Jr, Buhac I., Farrar J. T., Swell L. Diminished bile acid pool size in patients with gallstones. Gastroenterology. 1970 Aug;59(2):165–173. [PubMed] [Google Scholar]
  44. Vlahcevic Z. R., Bell C., Jr, Swell L. Significance of the liver in the production of lithogenic bile in man. Gastroenterology. 1970 Jul;59(1):62–69. [PubMed] [Google Scholar]
  45. Yousef I. M., Fisher M. M. Bile acid metabolism in mammals. VIII. Biliary secretion of cholylarginine by the isolated perfused rat liver. Can J Physiol Pharmacol. 1975 Oct;53(5):880–887. doi: 10.1139/y75-121. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES